Overview interest facts - Monitoring & Reducing Medication Errors: High Risk Medicines & Patient Groups 2024
This conference unites healthcare professionals to discuss medication safety, focusing on high-risk medications and patient groups. It also covers the Patient Safety Incident Response Framework and offers exhibition and sponsorship opportunities for industry suppliers.
A month after Novartis made its entry into the paroxysmal nocturnal haemoglobinuria (PNH) field, AstraZeneca’s newest contender Voydeya bolsters the company’s presence...22 January 2024
Researchers in Ireland have combined antimicrobial implants and gene therapies to develop a new surgical solution with the potential to improve the treatment of comple...29 November 2023
In 2016, the research team conducted an initial study in southern Sweden (Skåne) where they revealed that sepsis is much more common than previously believed.04 September 2023
Following the approval, Biogen plans for the commercial launch Zurzuvae (zuranolone) in Q4 2023.10 August 2023
A new multi-cancer early detection blood test could speed up diagnosis.16 June 2023
The European Union on April 26 has released a draft of the probable and proposed revamp of its drug manufacturing laws04 May 2023